Back to search

United Kingdom· GB-APID-13966711000001100

Vaniqa 11.5% cream

A eflornithine product containing eflornithine, registered in United Kingdom by DE Pharmaceuticals. The same ATC class is registered in 12 of our 19 countries.

ATC D11AX16

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedVaniqa 11.5% creamATCD11AX16REGISTER NO.GB-APID-1396671100000…PACKS LISTED0CHECKEDSeptember 13, 2026

Where it is registered

Eflornithine is registered in 12 of 19 countries.

Countries holding a registration under ATC D11AX16 (eflornithine), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 7 of them publish a price we can compare per daily dose

Eflornithine · ATC D11AX16

12 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Eflornithine
Manufacturer
DE Pharmaceuticals
Country
United Kingdom (GB)
ATC code
D11AX16
ATC class
Eflornithine
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Eflornithine in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All eflornithine products

Authorised across Europe · EMA

The same active substance is authorised in 4 EEA countries. Names it is sold under:

  • France · Ornidyl
  • Iceland · Vaniqa
  • Liechtenstein · Vaniqa
  • Norway · Vaniqa

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/a39a62cc-5c42-4a38-8ffa-8e816c71c9e1
GET /v1/drugs/a39a62cc-5c42-4a38-8ffa-8e816c71c9e1?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "13966711000001100",
  "desc": "Vaniqa 11.5% cream (DE Pharmaceuticals)",
  "form": "Cutaneous cream",
  "vpid": "39691811000001104",
  "source": "dmd",
  "vtm_id": "775738006",
  "strength": "115 mg",
  "substance": "Eflornithine",
  "ingredient": "Eflornithine hydrochloride monohydrate",
  "supplier_code": "2268901000001109"
}

See everything about eflornithine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.